Detalles de la búsqueda
1.
Low incidence of tumor lysis syndrome in elderly patients with chronic lymphocytic leukemia treated with venetoclax under real-world conditions: results from the prospective observational VeRVe study.
Ann Hematol
; 103(6): 2013-2020, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38421404
2.
Association between serum IgG concentrations and the incidence of infections in patients with chronic lymphocytic leukemia and secondary immunodeficiency under treatment with Privigen.
Int J Clin Pharmacol Ther
; 62(6): 241-249, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38577752
3.
Health status and infections in patients with symptomatic primary and secondary immunoglobulin G (IgG) deficiencies receiving intravenous IgG replacement.
BMC Immunol
; 21(1): 39, 2020 06 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32600256
4.
Rare lymphomas in routine practice-Treatment and outcome in Waldenström's macroglobulinaemia in the prospective German Tumour Registry Lymphatic Neoplasms.
Hematol Oncol
; 38(3): 344-352, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32383192
5.
Real-world use and acceptance of rituximab biosimilars in non-Hodgkin lymphoma in an oncologist network in Germany.
Future Oncol
; 16(15): 1001-1012, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32286864
6.
High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany.
Support Care Cancer
; 27(11): 4265-4271, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30859307
7.
A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study.
Breast Cancer Res Treat
; 161(1): 63-72, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27798749
8.
Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study.
J Allergy Clin Immunol
; 138(1): 210-218.e9, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27221134
9.
Response to the letter to the Editor concerning our article "High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany".
Support Care Cancer
; 28(1): 3-4, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31701271
10.
Characteristics of episodic breathlessness as reported by patients with advanced chronic obstructive pulmonary disease and lung cancer: Results of a descriptive cohort study.
Palliat Med
; 29(5): 420-8, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25634633
11.
REFLECT: prospective multicenter non-interventional study evaluating the effectiveness and safety of Sandoz rituximab (SDZ-RTX; Rixathon®) in combination with CHOP for the treatment of patients with previously untreated CD20-positive diffuse large B-cell lymphoma.
Ther Adv Hematol
; 14: 20406207231183765, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37492394
12.
Early versus Delayed Tumor-Specific Therapy and Survival in Patients with Lung Cancer: A Retrospective Study.
Oncol Res Treat
; 46(6): 227-235, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37054696
13.
PRECYCLE: multicenter, randomized phase IV intergroup trial to evaluate the impact of eHealth-based patient-reported outcome (PRO) assessment on quality of life in patients with hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer treated with palbociclib and an aromatase inhibitor or palbociclib and fulvestrant.
Trials
; 24(1): 338, 2023 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37198674
14.
Patient assessment and feasibility of treatment in older patients with cancer: results from the IN-GHO® Registry.
J Cancer Res Clin Oncol
; 147(11): 3183-3194, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34312732
15.
Bortezomib in relapsed multiple myeloma: results of a non-interventional study by office-based haematologists.
Onkologie
; 32(4): 175-80, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19372712
16.
Home administration of filgrastim (Nivestim™) in primary prophylaxis of chemotherapy-induced febrile neutropenia.
Patient Prefer Adherence
; 12: 2179-2186, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30410313
17.
Geriatric assessment and biomarkers in patients with metastatic breast cancer receiving first-line mono-chemotherapy: Results from the randomized phase III PELICAN trial.
J Geriatr Oncol
; 9(2): 163-169, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29055624
18.
Compatibility of Biosimilar Filgrastim with Cytotoxic Chemotherapy during the Treatment of Malignant Diseases (VENICE): A Prospective, Multicenter, Non-Interventional, Longitudinal Study.
Adv Ther
; 33(11): 1983-2000, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27743353
19.
Treatment of refractory stage IV mycosis fungoides with bexarotene monotherapy.
Dermatol Clin
; 26 Suppl 1: 51-2, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18405188
20.
[WINHO quality indicators for outpatient oncology care in Germany]. / WINHO-Qualitätsindikatoren für die ambulante onkologische Versorgung in Deutschland.
Z Evid Fortbild Qual Gesundhwes
; 107(8): 548-59, 2013.
Artículo
en Alemán
| MEDLINE | ID: mdl-24290669